Ondansetron Tablet, Orally Disintegrating
Product Images NDC 57237-078

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 57237-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))

Ondansetron Orally Disintegrating Tablets USP 4 mg label with dosage form as orally disintegrating tablets and package count of 30 tablets. Label includes information on active ingredient strength, storage conditions, dispensing instructions, and notes that the product is distributed by Rising Health, LLC and made in India. NDC 57237-077-30 is shown along with a barcode and coding area instructions.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Ondansetron Orally Disintegrating Tablets, USP, 4 mg strength, by Rising Pharma Holdings, Inc. The label states there are 30 tablets (3 blister cards of 10 tablets each). The label includes dosage warnings, storage instructions, barcode, and distribution details. The product is Rx only and made in India.*

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

Ondansetron Orally Disintegrating Tablets USP 8 mg in a 30-tablet package by Rising Pharma Holdings, Inc. The label includes storage instructions, phenylketonurics warning, distributor information (Rising Health, LLC, Saddle Brook, NJ), and product origin (Made in India). It is marked for prescription use only.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Ondansetron Orally Disintegrating Tablets, USP 8 mg by Rising Pharma Holdings, Inc. The label shows a 30 count blister pack (3 blister cards of 10 tablets each) with dosage form as orally disintegrating tablets. The label includes directions, storage instructions, and manufacturer information, with the NDC 57237-078-10.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure diagram of ondansetron, showing its molecular framework including fused ring systems and functional groups typical of the active ingredient ondansetron.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.